Terms: = Breast cancer AND SUZ12, CHET9, 23512, ENSG00000178691, Q15022, KIAA0160, JJAZ1 AND Treatment
9 results:
1. ESR1 hotspot mutations in endometrial stromal sarcoma with high-grade transformation and endocrine treatment.
Dessources K; Miller KM; Kertowidjojo E; Da Cruz Paula A; Zou Y; Selenica P; da Silva EM; Benayed R; Ashley CW; Abu-Rustum NR; Dogan S; Soslow RA; Hensley ML; Weigelt B; Chiang S
Mod Pathol; 2022 Jul; 35(7):972-978. PubMed ID: 34961764
[TBL] [Abstract] [Full Text] [Related]
2. Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments.
Mieczkowska IK; Pantelaiou-Prokaki G; Prokakis E; Schmidt GE; Müller-Kirschbaum LC; Werner M; Sen M; Velychko T; Jannasch K; Dullin C; Napp J; Pantel K; Wikman H; Wiese M; Kramm CM; Alves F; Wegwitz F
Cell Death Dis; 2021 Nov; 12(12):1118. PubMed ID: 34845197
[TBL] [Abstract] [Full Text] [Related]
3. PRMT1-mediated EZH2 methylation promotes breast cancer cell proliferation and tumorigenesis.
Li Z; Wang D; Chen X; Wang W; Wang P; Hou P; Li M; Chu S; Qiao S; Zheng J; Bai J
Cell Death Dis; 2021 Nov; 12(11):1080. PubMed ID: 34775498
[TBL] [Abstract] [Full Text] [Related]
4. TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells.
Crawford NT; McIntyre AJ; McCormick A; D'Costa ZC; Buckley NE; Mullan PB
Oncogene; 2019 Aug; 38(31):5971-5986. PubMed ID: 31253870
[TBL] [Abstract] [Full Text] [Related]
5. ERG induces a mesenchymal-like state associated with chemoresistance in leukemia cells.
Mochmann LH; Neumann M; von der Heide EK; Nowak V; Kühl AA; Ortiz-Tanchez J; Bock J; Hofmann WK; Baldus CD
Oncotarget; 2014 Jan; 5(2):351-62. PubMed ID: 24504051
[TBL] [Abstract] [Full Text] [Related]
6. A family of pleiotropically acting microRNAs in cancer progression, miR-200: potential cancer therapeutic targets.
Zhang HF; Xu LY; Li EM
Curr Pharm Des; 2014; 20(11):1896-903. PubMed ID: 23888967
[TBL] [Abstract] [Full Text] [Related]
7. Aberrations of EZH2 in cancer.
Chase A; Cross NC
Clin Cancer Res; 2011 May; 17(9):2613-8. PubMed ID: 21367748
[TBL] [Abstract] [Full Text] [Related]
8. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
Glinsky GV
J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
[TBL] [Abstract] [Full Text] [Related]
9. Integration of HapMap-based SNP pattern analysis and gene expression profiling reveals common SNP profiles for cancer therapy outcome predictor genes.
Glinsky GV
Cell Cycle; 2006 Nov; 5(22):2613-25. PubMed ID: 17172834
[TBL] [Abstract] [Full Text] [Related]
